BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20853153)

  • 1. Shortened time interval between colorectal cancer diagnosis and risk testing for hereditary colorectal cancer is not related to higher psychological distress.
    Landsbergen KM; Prins JB; Brunner HG; Hoogerbrugge N
    Fam Cancer; 2011 Mar; 10(1):51-7. PubMed ID: 20853153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist's initiative.
    Landsbergen KM; Prins JB; Brunner HG; van Duijvendijk P; Nagengast FM; van Krieken JH; Ligtenberg M; Hoogerbrugge N
    Fam Cancer; 2012 Jun; 11(2):259-67. PubMed ID: 22311584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impact.
    Landsbergen KM; Prins JB; Brunner HG; Kraaimaat FW; Hoogerbrugge N
    Fam Cancer; 2009; 8(4):325-37. PubMed ID: 19330464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.
    Manne SL; Chung DC; Weinberg DS; Vig HS; Catts Z; Cabral MK; Shannon K; Meropol NJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2110-7. PubMed ID: 17932359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients.
    Landsbergen KM; Prins JB; Brunner HG; Hoogerbrugge N
    Genet Couns; 2009; 20(4):317-25. PubMed ID: 20162866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning.
    Esplen MJ; Madlensky L; Aronson M; Rothenmund H; Gallinger S; Butler K; Toner B; Wong J; Manno M; McLaughlin J
    Clin Genet; 2007 Nov; 72(5):394-401. PubMed ID: 17892499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-Based Lynch Syndrome Screening by Microsatellite Instability in Patients ≤50: Prevalence, Testing Determinants, and Result Availability Prior to Colon Surgery.
    Karlitz JJ; Hsieh MC; Liu Y; Blanton C; Schmidt B; Jessup JM; Wu XC; Chen VW
    Am J Gastroenterol; 2015 Jul; 110(7):948-55. PubMed ID: 25601013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
    Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
    Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
    Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
    Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
    Schofield L; Goldblatt J; Iacopetta B
    Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.
    Morrison J; Bronner M; Leach BH; Downs-Kelly E; Goldblum JR; Liu X
    Scand J Gastroenterol; 2011 Nov; 46(11):1340-8. PubMed ID: 21879804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumour examination to detect hereditary colorectal cancer].
    Hoogerbrugge N; Hermens RP; Nagengast F; Overbeek L; van Krieken HJ; Ligtenberg M
    Ned Tijdschr Geneeskd; 2012; 156(42):A4982. PubMed ID: 23075775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing.
    Hall MJ; Manne SL; Winkel G; Chung DS; Weinberg DS; Meropol NJ
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):249-54. PubMed ID: 21212064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
    Gritz ER; Peterson SK; Vernon SW; Marani SK; Baile WF; Watts BG; Amos CI; Frazier ML; Lynch PM
    J Clin Oncol; 2005 Mar; 23(9):1902-10. PubMed ID: 15774782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnostics.
    Bläker H; Haupt S; Morak M; Holinski-Feder E; Arnold A; Horst D; Sieber-Frank J; Seidler F; von Winterfeld M; Alwers E; Chang-Claude J; Brenner H; Roth W; Engel C; Löffler M; Möslein G; Schackert HK; Weitz J; Perne C; Aretz S; Hüneburg R; Schmiegel W; Vangala D; Rahner N; Steinke-Lange V; Heuveline V; von Knebel Doeberitz M; Ahadova A; Hoffmeister M; Kloor M;
    Int J Cancer; 2020 Nov; 147(10):2801-2810. PubMed ID: 32875553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer.
    Siraj AK; Prabhakaran S; Bavi P; Bu R; Beg S; Hazmi MA; Al-Rasheed M; Al-Assiri M; Sairafi R; Al-Dayel F; Al-Sanea N; Uddin S; Al-Kuraya KS
    Cancer; 2015 Jun; 121(11):1762-71. PubMed ID: 25712738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
    Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
    Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome.
    Tresallet C; Brouquet A; Julié C; Beauchet A; Vallot C; Ménégaux F; Mitry E; Radvanyi F; Malafosse R; Rougier P; Nordlinger B; Laurent-Puig P; Boileau C; Emile JF; Muti C; Penna C; Hofmann-Radvanyi H
    Int J Cancer; 2012 Mar; 130(6):1367-77. PubMed ID: 21520036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.